What is International Display Advertising Inc?
, a medical device company, engages in the development of non-invasive devices for various medical indications.
IRME · Verdict
Limited reward · high risk
IRME has limited near-term tailwinds — cash flow and volatility weigh on the model output.
Based on 88% data coverage
IRME · Verdict
Weak vs peers
Weak vs peers
-5349% return on equity
Earnings -20.1% CAGR
Model-based scoring. For information only — not financial advice.
, a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 109.81K.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.